Receptor for Advanced Glycation End Products: A New Theraputic Target for Chronic Obstructive Pulmonary Disease?
Lei Chen(Sichuan University), Fuqiang Wen(Sichuan University), Yongchun Shen(Sichuan University), Lin Liu(Oklahoma State University), Tao Wang(Heilongjiang University of Chinese Medicine)
Cited by 10
Related Papers
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.8k
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
|The Lancet|2019|773
Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection
|Gastroenterology|2009|354
The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress
|Current Neuropharmacology|2020|283